Table 2 Prevalence of epilepsy by age group, gender, health area and ivermectin use
Number of cases | Total sample | Epilepsy prevalence (%) (95% CI) | |
|---|---|---|---|
Age groups | |||
0–9 | 14 | 472 | 3.0 (1.8–4.9) |
10–19 | 21 | 374 | 5.6 (3.7–8.4) |
20–29 | 14 | 170 | 8.2 (5.0–13.4) |
30+ | 15 | 352 | 4.3 (2.6–6.9) |
Total | 64 | 1368 | 4.7 (3.7–5.9) |
Gender | |||
Male | 30 | 669 | 4.5 (3.2–6.3) |
Female | 34 | 705 | 4.8 (3.5–6.7) |
Total | 64 | 1374 | 4.7 (3.7–5.9) |
Health area | |||
Draju | 35 | 645 | 5.4 (3.9–7.5) |
Kanga | 29 | 744 | 3.9 (2.7–5.5) |
Total | 64 | 1389 | 4.6 (3.6–5.8) |
Ivermectin use | |||
Yes | 3 | 38 | 7.9 (2.7–20.8) |
No | 61 | 1351 | 4.5 (3.5–5.8) |
Total | 64 | 1389 | 4.6 (3.6–5.8) |